Study finds that de-escalating bone-modifying therapy is safe and effective in Metastatic Breast Cancer

At the European Society for Medical Oncology Congress meeting in October 2025, research demonstrating an effective approach for patients with breast cancer bone metastases was presented by Terry L. Ng, M.D., of the Ottawa Hospital Research Institute in Canada and Criterium’s Academic Breast Cancer Consortium (ABRCC).

Learn more about the study results

Identifying ways to empower ALK+ NSCLC patients in their decision making

At the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer, Thomas E. Stinchcombe, M.D., of Duke Cancer Institute and Criterium’s Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) presented an abstract detailing methods and tools to empower ALK+ NSCLC patients in their decision making.

Learn about ways to empower ALK+ NSCLC patients in their decision making